European Foundation for the Study of Diabetes
🇩🇪Germany
Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 1
1 (33.3%)Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)
- First Posted Date
- 2010-07-12
- Last Posted Date
- 2018-07-31
- Lead Sponsor
- European Foundation for the Study of Diabetes
- Target Recruit Count
- 30
- Registration Number
- NCT01159847
- Locations
- 🇨🇳
Diabetes Center, Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China
News
No news found